101 related articles for article (PubMed ID: 25455655)
1. Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: short report from a single centre.
Alizadeh H; Jaafar H; Rajnics P; Khan MI; Kajtár B
Leuk Res; 2015 Jan; 39(1):47-51. PubMed ID: 25455655
[TBL] [Abstract][Full Text] [Related]
2. Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor.
Zhou L; You JH; Wu W; Li JM; Shen ZX; Wang AH
Leuk Res; 2013 Oct; 37(10):1216-21. PubMed ID: 23937984
[TBL] [Abstract][Full Text] [Related]
3. [Pregnancy outcome among patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors].
Jiang Q; Jiang B; Chen SS; Jiang H; Qin YZ; Lai YY; Shi HX; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):6-9. PubMed ID: 22575184
[TBL] [Abstract][Full Text] [Related]
4. Outcome of 3 pregnancies in a patient with chronic myeloid leukemia who received 3 types of tyrosine kinase inhibitors each in different pregnancy: follow-up of the case with a review of published reports.
Alizadeh H; Jaafar H; Kajtár B
Ann Saudi Med; 2015; 35(6):468-71. PubMed ID: 26657232
[TBL] [Abstract][Full Text] [Related]
5. Managing pregnancy in chronic myeloid leukaemia.
Palani R; Milojkovic D; Apperley JF
Ann Hematol; 2015 Apr; 94 Suppl 2():S167-76. PubMed ID: 25814083
[TBL] [Abstract][Full Text] [Related]
6. Twin pregnancy in a patient of chronic myeloid leukemia on imatinib therapy.
Meera V; Jijina F; Shrikande M; Madkaikar M; Ghosh K
Leuk Res; 2008 Oct; 32(10):1620-2. PubMed ID: 18420270
[TBL] [Abstract][Full Text] [Related]
7. Management of chronic myelogenous leukemia in pregnancy.
Bhandari A; Rolen K; Shah BK
Anticancer Res; 2015 Jan; 35(1):1-11. PubMed ID: 25550528
[TBL] [Abstract][Full Text] [Related]
8. Chronic Myelogenous Leukemia: Pregnancy in the Era of Stopping Tyrosine Kinase Inhibitor Therapy.
Berman E; Druker BJ; Burwick R
J Clin Oncol; 2018 Apr; 36(12):1250-1256. PubMed ID: 29447062
[No Abstract] [Full Text] [Related]
9. Pregnancy among patients with chronic myeloid leukemia treated with imatinib.
Ault P; Kantarjian H; O'Brien S; Faderl S; Beran M; Rios MB; Koller C; Giles F; Keating M; Talpaz M; Cortes J
J Clin Oncol; 2006 Mar; 24(7):1204-8. PubMed ID: 16446320
[TBL] [Abstract][Full Text] [Related]
10. [Clinical analysis about the management and the perinatal outcomes of pregnancy with chronic myeloid leukemia].
Wang DP; Liang MY; Zhang XH; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):735-9. PubMed ID: 21176552
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy: part of life in chronic myelogenous leukemia.
Law AD; Dong Hwan Kim D; Lipton JH
Leuk Lymphoma; 2017 Feb; 58(2):280-287. PubMed ID: 27389567
[TBL] [Abstract][Full Text] [Related]
12. Pregnancy in a patient receiving busulphan for chronic myeloid leukaemia.
Norhaya MR; Cheong SK; Hamidah NH; Ainoon O
Singapore Med J; 1994 Feb; 35(1):102-3. PubMed ID: 8009265
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
Buyukbayrak EE; Ergen B; Karsidag YK; Kars B; Turan C; Argon D
Arch Gynecol Obstet; 2008 Aug; 278(2):161-3. PubMed ID: 18193246
[TBL] [Abstract][Full Text] [Related]
14. Chronic myeloid leukemia with pregnancy: Successful management of pregnancy and delivery with hydroxyurea and imatinib continued till delivery.
Yadav U; Solanki SL; Yadav R
J Cancer Res Ther; 2013; 9(3):484-6. PubMed ID: 24125987
[TBL] [Abstract][Full Text] [Related]
15. Chronic myeloid leukaemia in pregnancy: call for guidelines.
P P; Samal R; Ghose S
J Obstet Gynaecol; 2019 May; 39(4):582-583. PubMed ID: 30744447
[TBL] [Abstract][Full Text] [Related]
16. Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients.
Meggyesi N; Kozma A; Halm G; Nahajevszky S; Bátai A; Fekete S; Barta A; Ujj G; Lueff S; Sipos A; Adám E; Bors A; Reményi P; Masszi T; Tordai A; Andrikovics H
Acta Haematol; 2012; 127(1):34-42. PubMed ID: 22005133
[TBL] [Abstract][Full Text] [Related]
17. BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naïve and -exposed Southeast Asian chronic myeloid leukemia patients.
Wongboonma W; Thongnoppakhun W; Auewarakul CU
Exp Mol Pathol; 2012 Apr; 92(2):259-65. PubMed ID: 22314255
[TBL] [Abstract][Full Text] [Related]
18. Hydroxyurea treatment for chronic myeloid leukemia during pregnancy.
Celiloglu M; Altunyurt S; Undar B
Acta Obstet Gynecol Scand; 2000 Sep; 79(9):803-4. PubMed ID: 10993110
[No Abstract] [Full Text] [Related]
19. Management of chronic myeloid leukemia during pregnancy among patients treated with a tyrosine kinase inhibitor: a single-Center experience.
Assi R; Kantarjian H; Keating M; Pemmaraju N; Verstovsek S; Garcia-Manero G; Ravandi F; Borthakur G; Dahl J; Jabbour E; Cortes JE
Leuk Lymphoma; 2021 Apr; 62(4):909-917. PubMed ID: 33283580
[TBL] [Abstract][Full Text] [Related]
20. Successful pregnancies in patients with BCR-ABL-positive leukemias treated with interferon-alpha therapy during the tyrosine kinase inhibitors era.
Balsat M; Etienne M; Elhamri M; Hayette S; Salles G; Thomas X
Eur J Haematol; 2018 Dec; 101(6):774-780. PubMed ID: 30179268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
